rs751603399
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001171613.2(PREPL):c.1828A>T(p.Ile610Phe) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000223 in 1,611,530 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001171613.2 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PREPL | NM_001171613.2 | c.1828A>T | p.Ile610Phe | missense_variant, splice_region_variant | 14/14 | ENST00000409411.6 | NP_001165084.1 | |
SLC3A1 | NM_000341.4 | c.*806T>A | 3_prime_UTR_variant | 10/10 | ENST00000260649.11 | NP_000332.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PREPL | ENST00000409411.6 | c.1828A>T | p.Ile610Phe | missense_variant, splice_region_variant | 14/14 | 1 | NM_001171613.2 | ENSP00000387095 | P4 | |
SLC3A1 | ENST00000260649.11 | c.*806T>A | 3_prime_UTR_variant | 10/10 | 1 | NM_000341.4 | ENSP00000260649 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152120Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000104 AC: 26AN: 249710Hom.: 0 AF XY: 0.0000666 AC XY: 9AN XY: 135134
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1459410Hom.: 0 Cov.: 30 AF XY: 0.0000138 AC XY: 10AN XY: 726112
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152120Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74322
ClinVar
Submissions by phenotype
Myasthenic syndrome, congenital, 22 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 16, 2022 | This sequence change replaces isoleucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 699 of the PREPL protein (p.Ile699Phe). This variant is present in population databases (rs751603399, gnomAD 0.08%). This variant has not been reported in the literature in individuals affected with PREPL-related conditions. ClinVar contains an entry for this variant (Variation ID: 570518). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 16, 2022 | The c.2095A>T (p.I699F) alteration is located in exon 14 (coding exon 14) of the PREPL gene. This alteration results from a A to T substitution at nucleotide position 2095, causing the isoleucine (I) at amino acid position 699 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at